The abstract is read at the publisher; the summary is JClub's.
In a C57BL/6J mouse cholesterol crystal embolism kidney model, CCR5 and CD74 inhibition reduced vascular thrombosis and tissue damage, even when given 2 hours after embolism.
- Why it matters: A single-cell map of CCE kidney biology is incomplete, limiting rational therapies for necroinflammation that can culminate in AKI from ischemic cortical necrosis.
- What they did: Using unilateral renal artery cholesterol crystal injection, single-cell transcriptomics across 17 kidney cell types identified DEGs, and cell-cell interaction analyses highlighted CCR5 and CD74 pathways; mice then received maraviroc or milatuzumab alone or combined.
- The result: CCR5 or CD74 blockade (alone or together) lowered thrombotic angiopathy and AKI and reduced immune infiltration, while human CCE biopsies showed CD74-positive staining near obstructed arteries with cholesterol clefts.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.